RYGB, duodenal switch show positive results in diabetes patients

11/10/2011 | Medscape (free registration)

Roux-en-Y gastric bypass was superior to nonsurgical treatment and laparoscopic adjustable gastric band surgery in terms of weight loss, mean A1C improvements and reduction in medication score for morbidly obese patients with type 2 diabetes, a study revealed. Researchers said RYGB and duodenal switch patients achieved similar weight loss and body mass index, but those who had the latter showed better A1C and diabetes medication scores and had higher diabetes resolution. The findings appear in the Annals of Surgery.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD